Canopy Growth (CGC) Capital Expenditures (QoQ) (2019 - 2024)
Canopy Growth (CGC) Capital Expenditures (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -54.17% |
| Sep 30, 2024 | -33.78% |
| Jun 30, 2024 | 1,451.02% |
| Mar 31, 2024 | -55.40% |
| Dec 31, 2023 | -19.51% |
| Sep 30, 2023 | -64.47% |
| Jun 30, 2023 | -33.34% |
| Mar 31, 2023 | 57.92% |
| Dec 31, 2022 | -10.93% |
| Sep 30, 2022 | -14.10% |
| Jun 30, 2022 | 3,459.51% |
| Mar 31, 2022 | -93.38% |
| Dec 31, 2021 | -93.75% |
| Sep 30, 2021 | -25.95% |
| Jun 30, 2021 | -83.97% |
| Mar 31, 2021 | 339.78% |
| Dec 31, 2020 | -299.66% |
| Sep 30, 2020 | -51.57% |
| Jun 30, 2020 | -90.96% |
| Mar 31, 2020 | 892.50% |